Pathogenic Lysosomal Depletion in Parkinson's DiseaseBenjamin Dehay, Miquel Vila|Journal of Neuroscience|2010Cited by 802
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerationsBenjamin Dehay, Wassilios G. Meissner, Mathieu Bourdenx et al.|The Lancet Neurology|2015Cited by 508
Exosomes, an Unmasked Culprit in Neurodegenerative DiseasesFederico N. Soria, Benjamin Dehay|Frontiers in Neuroscience|2017Cited by 134
Transcription factor EB overexpression prevents neurodegeneration in experimental synucleinopathiesMarie-Laure Arotçarena, Benjamin Dehay|JCI Insight|2019Cited by 79
Acidic nanoparticles protect against α‐synuclein‐induced neurodegeneration through the restoration of lysosomal functionMarie-Laure Arotçarena, Benjamin Dehay|Aging Cell|2022Cited by 51